Vivos Therapeutics, Inc. (VVOS)


-0.02 (-5.48%)
Symbol VVOS
Price $0.331
Beta 2.832
Volume Avg. 2.99M
Market Cap 8.279M
Shares () -
52 Week Range 0.302-2.962
1y Target Est -
DCF Unlevered VVOS DCF ->
DCF Levered VVOS LDCF ->
ROE -215.11% Strong Sell
ROA -207.77% Strong Sell
Operating Margin -
Debt / Equity 86.71% Buy
P/E -0.28 Neutral
P/B 0.71 Buy


Consensus EPS

Upgrades & Downgrades

Latest VVOS news

Mr. R. Kirk Huntsman
Medical Devices
NASDAQ Capital Market

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.